Joseph Mikhael, MD, MEd, highlights the clinical and logistical advantages of the novel on-body injector developed for the ...
Sanofi ( (SNY)) just unveiled an announcement. On July 10, 2026, the U.S. Food and Drug Administration approved Sanofi’s subcutaneous Sarclisa Escena, in combination with standard-of-care regimens, ...
By Sneha S K and Bhanvi Satija July 10 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved a ...
In 2015, the Neulasta On-Body Injector (OBI) Onpro device was introduced as a less costly method of pegfilgrastim administration. While the device has been found to be safe in healthy volunteers and ...
Dublin, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The "Epinephrine Auto-Injection Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Epinephrine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results